Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Can high bone turnover markers identify osteopenic postmenopausal women at risk of future fracture?

Nature Clinical Practice Endocrinology & Metabolism volume 3, pages 570–571 (2007)Cite this article

boxed-textSchousboe JT et al. (2007) Potential for bone turnover markers to cost-effectively identify and select post-menopausal osteopenic women at high risk of fracture for bisphosphonate therapy. Osteoporos Int 18: 201–210

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Bauer DC et al. (2006) Pretreatment levels of bone turnover and the anti-fracture efficacy of alendronate: the Fracture Intervention Trial. J Bone Miner Res 21: 292–299

    Article  CAS  Google Scholar 

  2. Cummings SR et al. (1998) Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA 280: 2077–2082

    Article  CAS  Google Scholar 

  3. McClung MR et al. (2001) Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med 344: 333–340

    Article  CAS  Google Scholar 

  4. Chesnut CH III et al. (2004) Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res 19: 1241–1249

    Article  CAS  Google Scholar 

  5. McCloskey EV et al. (2007) Clodronate reduces the incidence of fractures in community-dwelling elderly women unselected for osteoporosis: results of a double-blind, placebo-controlled randomized study. J Bone Miner Res 22: 135–141

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Vicky Heath, Associate Editor, Nature Clinical Practice. DM Reid is grateful to the UK Arthritis Research Campaign for continued infra-structure support.

Author information

Author notes

  1. University of Aberdeen, Medical School, Foresterhill, Aberdeen AB25 2ZD, UK d.m.reid@abdn.ac.uk

Authors and Affiliations

  1. DM Reid is Professor of Rheumatology and Head of the Department of Medicine and Therapeutics, University of Aberdeen, UK.,

    David M Reid

Authors
  1. David M Reid
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

GlaxoSmithKline: consultant, speakers bureau and research support; Merck: speakers bureau; Procter and Gamble: consultant; Roche: consultant, speakers bureau and research support.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reid, D. Can high bone turnover markers identify osteopenic postmenopausal women at risk of future fracture?. Nat Rev Endocrinol 3, 570–571 (2007). https://doi.org/10.1038/ncpendmet0560

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpendmet0560

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing